Nutrition, Exercise, & Translational Medicine Lab Director Kembra Albracht-Schulte

Overview

It has been predicted that by 2030, 57.8% of the adult population worldwide will be overweight or obese, defined as having abnormal or excessive fat accumulation. Obesity associated low-grade systemic inflammation promotes dyslipidemia and dysglycemia and contributes to the development of obesity related metabolic diseases, including type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), and cardiovascular diseases (CVD), among others.

Lab Focus

Dr. Albracht-Schulte's research efforts aim to understand the mechanistic and potentially synergistic effects of exercise (intensity vs. duration) and nutrition (e.g. foods, nutrients, food bioactives and supplements) interventions by conducting clinical and translational research. Ultimately, this will help us understand inter-individual differences in chronic disease susceptibility and to design treatment utilizing optimized and targeted exercise and diet interventions.